We’re pleased to share that we will be attending BAXTERNA’s upcoming “Next-generation mRNA Vaccines Against Complex Pathogens” event, happening March 25–26, 2026, in Leuven, Belgium.

What can you expect?

• A presentation of a next-generation mRNA vaccine development targeting Mycobacterium tuberculosis, Mycobacterium ulcerans, and Acinetobacter baumannii
• Insights into antigen discovery using advanced immunopeptidomics
• Discussion on scalable, cost-efficient production and formulation strategies geared toward stable, broadly accessible vaccines

Connect with us: we support vaccine R&D with analytical expertise ranging from antigen characterization and method optimization to impurity profiling and LC–MS workflows. If you’re attending, feel free to reach out to Thomas Martens (BD & Sales Manager – Team Lead).